Contact our responsive and friendly client services team any time.
(03) 9028 2888
clients@freshequities.com
INVESTOR PRESENTATION - Mayne Pharma Group Limited
Health
Mayne Pharma Group Limited (MYX) is a pharmaceutical company that develops and manufactures branded and generic products, which it distributes directly or through distribution partners in Australia, USA, Europe and Asia. Mayne Pharma has two drug development and manufacturing facilities based in Salisbury, Australia and Greenville, NC, USA. Former Names Halcygen Pharmaceuticals Limited (HGN), 18/11/2010
Read moreMarket Cap
Price at Close
4w avg. Volume
4w avg. Turnover
announcement | t+2 movement | date |
---|---|---|
| +1.43% | 06 Jan 2021 |
| 0.00% | 17 Dec 2020 |
| +2.78% | 04 Dec 2020 |
| +2.78% | 04 Dec 2020 |
| +1.41% | 24 Nov 2020 |
| 0.00% | 23 Nov 2020 |
| -1.54% | 09 Nov 2020 |
| -3.13% | 25 Oct 2020 |
| -3.08% | 23 Oct 2020 |
| +3.13% | 14 Oct 2020 |
Current Price
52WK HIGH
52WK LOW
1YR RETURN
1YR RETURN VS. SECTOR
90 DAY RETURN
ASX RANK
/2,047
SECTOR RANK
/168
SHARES OUTSTANDING
Health
Mayne Pharma Group Limited (MYX) is a pharmaceutical company that develops and manufactures branded and generic products, which it distributes directly or through distribution partners in Australia, USA, Europe and Asia. Mayne Pharma has two drug development and manufacturing facilities based in Salisbury, Australia and Greenville, NC, USA. Former Names Halcygen Pharmaceuticals Limited (HGN), 18/11/2010
Read moreMarket Cap
Price at Close
4w avg. Volume
4w avg. Turnover
ASX:MYX is not raising right now
Want to invest?
(03) 9028 2888
clients@freshequities.com
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia